Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

Caristo Secures FDA Clearance, Ushering in a New Era of AI-Powered Heart Attack Prevention

FDA 510(k) clearance of Caristo’s CaRi-Plaque™ technology advances AI innovator’s U.S. commercialization, as it looks to roll…

Continue Reading
Organon calls for greater awareness on Cardiovascular Disease Prevention for women

Organon calls for greater awareness on Cardiovascular Disease Prevention for women

Cardiovascular disease (CVD) remains the leading cause of death among women worldwide, yet it continues to…

Continue Reading
Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Seeing is believing. Patients shown proof of calcification adhered better to statins; those without CAC avoided…

Continue Reading
‘Concerningly Low’ Use of CVD Meds for Secondary Prevention

‘Concerningly Low’ Use of CVD Meds for Secondary Prevention

TOPLINE: Among patients with ­cardiovascular disease (CVD) in 17 countries, many receive no medication for secondary…

Continue Reading
Application of decision analytic modelling to cardiovascular disease prevention in Sub-Saharan Africa: a systematic review

Application of decision analytic modelling to cardiovascular disease prevention in Sub-Saharan Africa: a systematic review

Out of an initial 2033 results retrieved from the database search, the final review included 27…

Continue Reading
Cardiovascular disease – Coronary Artery, Risk Factors, Prevention

Cardiovascular disease – Coronary Artery, Risk Factors, Prevention

Table of Contents Table of Contents Ask the Chatbot a Question Operations have been devised to…

Continue Reading